Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors - Retrospective cohort analyses and a concept for prospective intervention

International Journal of Cancer

Volumn 124, Issue 8, 2009, Pages 1914-1917

  Andersson, Anne ^a   N̈aslund, Ulf ^b   Tavelin, Bj̈orn ^a   Enblad, Gunilla ^c   Gustavsson, Anita ^d   Malmer, Beatrice ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Hodgkin; Prevention; Survivorship

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY HISTORY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT CARE; PRIORITY JOURNAL; STROKE; VALVULAR HEART DISEASE; ADOLESCENT; ADULT; AGED; CHILD; COHORT ANALYSIS; COMORBIDITY; FOLLOW UP; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK;

EID: 62449265220     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24147     Document Type: Article

References (25)

1. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003;21:3431-3439
2. Hoppe RT. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 1997;8 (Suppl 1):115-118
3. Ng AK, Bernardo MP,Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch PM. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002;20:2101-2108 (Pubitemid 34408801)
4. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford JA, Rohatiner AZ, Linch DC. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007;99:206-214
5. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, van Leeuwen FE. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878-1886.
6. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE. Cardiovascular status in longterm survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-3148 (Pubitemid 41103728)
7. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 2003;290:2831-2837 (Pubitemid 37509491)
8. King V, Constine LS, Clark D, Schwartz RG, Muhs AG, Henzler M, Hutson A, Rubin P. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1996;36:881-889 (Pubitemid 27008604)
9. Basavaraju SR, Easterly CE. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002;29:2391-2403 (Pubitemid 35204448)
10. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. The New Engl J Med 1995;332:1738-1743
11. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003;42:743-749 (Pubitemid 37000197)
12. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007;25:43-49 (Pubitemid 350003049)
13. Constine LS, Schwartz RG, Savage DE, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997;39:897-906. (Pubitemid 27486078)
14. Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998;46:51-62. (Pubitemid 28072859)
15. Gustavsson A, Eskilsson J, Landberg T, Svahn-Tapper G, White T, Wollmer P, Akerman M. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990;1:355-363 (Pubitemid 20320488)
16. Schwartz RS, Jackson WG, Celio PV, Richardson LA, Hickman JR, Jr. Accuracy of exercise 201Tl myocardial scintigraphy in asymptomatic young men. Circulation 1993;87:165-172
17. Fazzini PF, Prati PL, Rovelli F, Antoniucci D, Menghini F, Seccareccia F, Menotti A. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol 1993;72:1383-1388 (Pubitemid 24005666)
18. Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-791 (Pubitemid 41125894)
19. Breslow NE, Day NE. Statistical methods in cancer research, vol.I: The analysis of case-control studies. Lyon, France: IARC, 1980.5-338
20. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nationwide Swedish family-cancer database-updated structure and familial rates. Acta Oncologica (Stockholm. Sweden) 2001;40:772-777 (Pubitemid 33081988)
21. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Buller HR, Sijbrands EJ, Kastelein JJ. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004;292:331-337 (Pubitemid 38944256)
22. Gustavsson A, Osterman B, Cavallin-Stahl E. A systematic overview of radiation therapy effects in Hodgkin's lymphoma. Acta oncologica (Stockholm. Sweden) 2003;42:589-604. (Pubitemid 37193847)
23. Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart (British Cardiac Society). 1996;75:591-595
24. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007;25:3991-4008. (Pubitemid 47477279)
25. Weinehall L, Westman G, Hellsten G, Boman K, Hallmans G, Pearson TA, Wall S. Shifting the distribution of risk: results of a community intervention in a Swedish programme for the prevention of cardiovascular disease. J Epidemiol Community Health 1999;53:243-250 (Pubitemid 29137688)